BRAINLIFE.ORG

Topics

Glioblastoma | Treatment | Targeted therapy

Home > Publications > Topics > Glioblastoma > Treatment > Targeted therapy

□ OVERVIEW

□ ¹⁷⁷LU-PSMA

□ AFATINIB

□ APATINIB

□ APTAMERS

■ BEVACIZUMAB

□ BOTENSILIMAB

□ BRAF-MEK-INHIBITORS

□ CILENGITIDE

□ ENTRECTINIB

□ ERDAFITINIB

□ GLUTAMATE SIGNALING INHIBITORS

□ IPILIMUMAB

□ MICROENVIRONMENT MODULATORS

□ NANOPARTICLES

□ NAVTEMADLIN

□ NIVOLUMAB

□ OLAPARIB

□ PEMBROLIZUMAB

□ PEMIGATINIB

□ RADIOPHARMACEUTICALS

□ REGORAFENIB

□ SACITUZUMAB GOVITECAN

□ SINTILIMAB

□ SUNITINIB

□ TELOMERASE-TARGETED THERAPY

□ TEPOTINIB

□ TISLELIZUMAB